STRO Overview
Upcoming Projects (STRO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (STRO)
-
Discussing Antibody Drug Conjugates for ovarian cancer with a focus on Immunogen's ELAHERE in advance of the upcoming MIRASOL confirmatory trial data & Mersana's Upifitamab Rilsodotin (UpRi)
Tickers: IMGN, MRSN, STRO
Executed On: Mar 17, 2023 at 01:00 PM EDT -
A Second Perspective: Examining the potential of STRO-002, Sutro's FolRα-targeting ADC in treating ovarian cancer
Ticker: STRO
Executed On: Mar 03, 2022 at 10:30 AM EST -
Examining the potential of STRO-002, Sutro's FolRα-targeting ADC in treating ovarian cancer
Ticker: STRO
Executed On: Feb 11, 2022 at 03:00 PM EST
Expired Projects (STRO)
-
Looking at Sutro Bio’s lead pipeline candidate, STRO-001 CD74-Targeting ADC for Lymphoma & Multiple Myeloma after its recent IPO
Ticker: STRO
Execute By: Jan 31, 2019
Upcoming & Overdue Catalysts (STRO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (STRO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
